Hematological Malignancy

Showing 51 - 59 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Cancer Patient Underwent Mechanical Ventillation

Completed
  • Hematological Malignancy
  • +2 more
  • Mechanical ventilation
  • Mansoura, Dakahlia, Egypt
    Mansoura Cancer Therapy Center
Sep 27, 2015

Solid Tumor, Hematological Malignancy Trial in Salt Lake City (Belinostat, Warfarin)

Completed
  • Solid Tumor
  • Hematological Malignancy
  • Belinostat, Warfarin
  • Salt Lake City, Utah
    Huntsman Cancer Center, University of Utah
Sep 21, 2015

Hematological Malignancy, Bone Marrow Failure Syndrome Trial in Jerusalem, Petach Tikva (Eltrombopag)

Unknown status
  • Hematological Malignancy
  • Bone Marrow Failure Syndrome
  • Jerusalem, Israel
  • +1 more
Jun 18, 2015

Effect of Body Mass on Acyclovir Pharmacokinetics

Completed
  • Hematological Malignancy
  • Pharmacokinetics of Acyclovir
    • Morgantown, West Virginia
      West Virginia University Hospitals Mary Babb Randolph Cancer Cen
    Jun 2, 2015

    Hematological Malignancy Trial in Leuven, Bucharest (Posaconazole prophylaxis 120 mg/m² tid, Blood sampling)

    Completed
    • Hematological Malignancy
    • Posaconazole prophylaxis 120 mg/m² tid
    • Blood sampling
    • Leuven, Vlaams-Brabant, Belgium
    • +1 more
    Mar 2, 2015

    Allograft, Allogeneic Cell Transplantaion, Hematological Malignancy Trial in France (reduced intensity conditionings)

    Completed
    • Allograft
    • +3 more
    • reduced intensity conditionings
    • Bordeaux Pessac, France
    • +4 more
    Dec 31, 2013

    Hematological Malignancy Trial in Creteil (donor lymphocyte infusion)

    Completed
    • Hematological Malignancy
    • donor lymphocyte infusion
    • Creteil, France
      Groupe Hospitalier Albert Chenevier-Henri Mondor
    Jan 11, 2013

    Hematological Malignancy, Tumor Metastasis Trial in Jerusalem (DLI sensitized against antigens expressed by the host.)

    Withdrawn
    • Hematological Malignancy
    • Neoplasm Metastasis
    • DLI sensitized against antigens expressed by the host.
    • Jerusalem, Israel
      Hadassah Medical Organization
    Apr 7, 2011

    Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus

    Completed
    • Hematological Malignancy
    • +5 more
    • Alcalá de Henares, Spain
    • +11 more
    Nov 13, 2009